Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Net Margin (2016 - 2025)

Historic Net Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 7.07%.

  • Nephros' Net Margin rose 18700.0% to 7.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.46%, marking a year-over-year increase of 153700.0%. This contributed to the annual value of 0.52% for FY2024, which is 115800.0% up from last year.
  • Nephros' Net Margin amounted to 7.07% in Q3 2025, which was up 18700.0% from 5.36% recorded in Q2 2025.
  • Over the past 5 years, Nephros' Net Margin peaked at 11.87% during Q1 2025, and registered a low of 134.12% during Q3 2022.
  • For the 5-year period, Nephros' Net Margin averaged around 25.73%, with its median value being 12.21% (2023).
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by -867200bps in 2022, then surged by 1292600bps in 2023.
  • Over the past 5 years, Nephros' Net Margin (Quarter) stood at 40.66% in 2021, then increased by 12bps to 35.89% in 2022, then skyrocketed by 44bps to 20.1% in 2023, then soared by 147bps to 9.41% in 2024, then fell by -25bps to 7.07% in 2025.
  • Its Net Margin stands at 7.07% for Q3 2025, versus 5.36% for Q2 2025 and 11.87% for Q1 2025.